Inherited and acquired genetic factors involved in the development of CLL
John Gribben et al.
Current thought on treating chronic lymphocytic leukemia
Marginalized and high-risk multiple myeloma patients: how to address this issue
The differences in treating older versus younger CLL patients
Results of the Phase III DASISION trial and the future of CML treatment